Cross-Linked Hydrogels For Soft Tissue Augmentation

Patent No. EP3520827 (titled "Cross-Linked Hydrogels For Soft Tissue Augmentation") was filed by Allergan on Mar 21, 2011. The application was issued on May 25, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MERZ AESTHETICSFeb 14, 2023JACOBI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3520827

ALLERGAN
Application Number
EP19157683A
Filing Date
Mar 21, 2011
Status
Revoked
Aug 25, 2023
Publication Date
May 25, 2022